After capturing record-breaking attendance at its spring Illuminate event, the Healthcare Businesswomen’s Association (HBA) brought together – virtually – the biggest Annual Conference crowd in the group’s history with more than 1,600 attendees from 15 countries representing 250 healthcare and life science companies.
With global attention on gender and racial inequities this year, the Healthcare Businesswomen’s Association (HBA) is proud to recognize BD (Becton, Dickinson and Company) GSK, Surgical Care Affiliates and Walgreens Boots Alliance with 2020 ACE Awards for exemplary workplace initiatives that are working to close the gender and racial inequities in the healthcare and life sciences industry.
After attending several virtual scientific conferences since the start of the COVID-19 lockdown, TBWA\WorldHealth explores which practices should stay, which ones will need to come back, and how pharmaceutical brands can stand out in this medium.
A review of recently published scientific studies includes a look at the potential of using flu and pneumonia vaccines to decrease the risk of developing Alzheimer’s disease.
Decentralized clinical trials gained a foothold in the pharmaceutical industry amidst the COVID-19 pandemic and will continue to be used once the pandemic ends, according to panelists at BIO 2020.
Biopharmaceutical companies need to look beyond the usual targets when addressing neurodegenerative disorders and also must work to correlate genetic changes to cognitive changes in patients, according to panelists at BIO’s on-demand session, “Battle of the Brains: Rethinking Neurodegenerative Disease Treatment.”
BIO 2020: Day 1 Kicked Off With New CEO, Focus on COVID-19 Published: June 9, 2020 By Alex Keown BioSpace The annual Biotechnology Innovation Organization (BIO) meeting kicked off Monday […]
One day, cell and gene therapies will be as common as small molecules and antibody-based therapies are today, according to panelists at BIO 2020.
Greater Than One’s Christa Toole analyzes how healthcare marketers are adjusting to the current health crisis in a variety of ways.
The Biotechnology Innovation Organization (BIO)’s annual meeting brings together some of the brightest minds across the industry to showcase advancements in developing therapeutics that will benefit people battling a myriad of diseases. The 2020 event, which kicks off June 8, will have a different look as an entirely digital conference.
